Seastar Medical Holding Corp (ICU) Live Share Price, Invest From India

Seastar Medical Holding Corp Stock Performance

as on November 15, 2025 at 2:29 am IST

Day's Low
Day's High
$0.36
Day's Price Range
$0.42
$0.38
5.26%
Downside
10.53%
Upside
52 Week's Low
52 Week's High
$0.31
52-Week Price Range
$3.07
$0.38
19.63%
Downside
707.89%
Upside

Seastar Medical Holding Corp share price movements today

Previous Close: $0.46
Open: $0.40
Volume: 2.9M
Day's Low - High: $0.36 - $0.42
52 Week Low - High: $0.31 - $3.07

Seastar Medical Holding Corp Historical Returns

1 Month Return: -19.18 %
3 Month Return: -47.72 %
1 Year Return: -76.53 %
3 Year Return: -99.65 %
5 Year Return: 0 %

Seastar Medical Holding Corp Stock Fundamentals & Key Indicators

Check Seastar Medical Holding Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$17.0M

EPS (TTM)

-0.72

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

766.0K

Profit Margin

0.00%

Return On Equity TTM

0.00%

Seastar Medical Holding Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Seastar Medical Holding Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Seastar Medical Holding Corp	BUY	$17.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$59.8B	235.01%	1414.81	1.36%
Beone Medicines Ltd	NA	$40.9B	NA	712.21	1.38%
Vertex Pharmaceuticals Incorporated	BUY	$110.2B	92.67%	30.58	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$71.6B	22.7%	16.34	32.13%

Stock Returns calculator for Seastar Medical Holding Corp Stock including INR - Dollar returns

The Seastar Medical Holding Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Seastar Medical Holding Corp investment value today

Current value as on today

₹24,630

Returns

₹75,370

(-75.37%)

Returns from Seastar Medical Holding Corp Stock

₹80,612 (-80.61%)

Dollar Returns*

₹5,242 (+5.24%)

Analyst Recommendation on Seastar Medical Holding Corp Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Seastar Medical Holding Corp. Average target price of $2

Seastar Medical Holding Corp Share Price Target

Get share price movements and forecasts by analysts on Seastar Medical Holding Corp.

What analysts predicted

81%UPSIDE

Target Price

Current Price

$0.38

Analyzed by

5 Analysts

Target

$2.00

Seastar Medical Holding Corp target price $2, a slight upside of 81% compared to current price of $0.38. According to 5 analysts rating.

Seastar Medical Holding Corp Stock’s Investor Sentiment and Interest

Search interest for Seastar Medical Holding Corp Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 18, 2025 to November 17, 2025

Change:-19% versus previous 30 day period

Seastar Medical Holding Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	0	0	0	0
Gross Profit	-	-	-	-	-	-	0	0	0	0
Operating Income	-4	-3	-2	-2	-3	-4	-4	-4	-3	-1
EBITDA	-4	-2	-7	-	-12	-3	-4	-4	-3	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-5	-3	-7	-9	-12	-3	-4	-4	-3	-2
Income Tax Expense	0	0	0	-	0	0	-	-	0	-
Net Income	-5	-3	-7	-9	-12	-3	-4	-4	-3	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-6585.29%	-6595.52%	-1287.37%	-592.31%

Seastar Medical Holding Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	0
Gross Profit	-	-	-	-	0
Operating Income	-6	-4	-11	-14	-17
EBITDA	0	-4	-11	-11	-24
Interest Expense	3	0	0	1	0
Depreciation	-	-	-	-	-
Income Before Tax	-3	-4	-23	-26	-24
Income Tax Expense	0	0	0	0	0
Net Income	-3	-4	-23	-26	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-18392.59%

Seastar Medical Holding Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-7	-9	-12	-3	-4	-4	-3	-2
Operating Cash Flow	-2	-1	-4	-3	-2	-5	-4	-2	-3
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	1	1	4	8	-1	5	4	6	4
Change in Cash	0	0	0	4	-3	0	0	3	1

Seastar Medical Holding Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-23	-26	-24
Operating Cash Flow	-5	-7	-10	-16
Investing Cash Flow	-105	-	-	-
Financing Cash Flow	2	7	10	17
Change in Cash	-2	0	0	1

Global Institutional Holdings in Seastar Medical Holding Corp

Funds	Holdings
UBS Group AG	0.33%
Geode Capital Management, LLC	0.25%
XTX Topco Ltd	0.22%
Vanguard Group Inc	0.21%
Virtu Financial LLC	0.14%

See all

Insights on Seastar Medical Holding Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 175.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.8% return, outperforming this stock by 177.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ICU stock has moved down by -22.5%

About Seastar Medical Holding Corp

SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Organisation	Seastar Medical Holding Corp
Headquarters	3513 Brighton Boulevard, Denver, CO, United States, 80216
CEO	Mr. Eric Schlorff
E-voting on shares	Click here to vote

Key Management of Seastar Medical Holding Corp

Name	Title
Colonel Kevin Chung FACP, M.D.	Chief Medical Officer
Dr. H. David Humes M.D.	Co-Founder & Scientific Advisor
Mr. Tom Mullen	Vice President of Operations & Product Development
Mr. Bradford K. Towne CPA	Principal Accounting Officer
Mr. Tim Varacek	Senior Vice President of Commercial & Business Operations
Mr. Sai P. Iyer Ph.D.	Senior Vice President of Medical Affairs & Research
Mr. Eric Schlorff	CEO, Interim Chief Financial Officer, Principal Financial Officer, Treasurer & Executive Director

FAQs

What is Seastar Medical Holding Corp share price today?

Seastar Medical Holding Corp share price today is $0.38 as on November 15, 2025 at 2:29 am IST at the close of the market. Seastar Medical Holding Corp share today touched a day high of $0.42 and a low of $0.36.

What is the 52 week high and 52 week low for Seastar Medical Holding Corp share?

Seastar Medical Holding Corp share touched a 52 week high of $3.07 on February 3, 2025 and a 52 week low of $0.31 on June 20, 2025. Seastar Medical Holding Corp stock price today i.e. November 15, 2025 at 2:29 am IST is closed at $0.38,which is 87.62% down from its 52 week high and 24.43% up from its 52 week low.

What is Seastar Medical Holding Corp's market capitalisation today?

Seastar Medical Holding Corp market capitalisation is $0.00T as on November 15, 2025 at 2:29 am IST.

How to invest in Seastar Medical Holding Corp Stock (ICU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Seastar Medical Holding Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seastar Medical Holding Corp Shares that will get you 3.9474 shares as per Seastar Medical Holding Corp share price of $0.38 per share as on November 15, 2025 at 2:29 am IST.

What is the minimum amount required to buy Seastar Medical Holding Corp Stock (ICU) from India?

Indian investors can start investing in Seastar Medical Holding Corp (ICU) shares with as little as ₹88.74 or $1 (as of November 17, 2025 at 2:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Seastar Medical Holding Corp stock (as per the Rupee-Dollar exchange rate as on November 17, 2025 at 2:37 am IST). Based on Seastar Medical Holding Corp share’s latest price of $0.38 as on November 15, 2025 at 2:29 am IST, you will get 26.3158 shares of Seastar Medical Holding Corp. Learn more about fractional shares .